Abstract
More than one million people with end-stage kidney disease are currently dependent for their continued survival on renal replacement therapy. Dialysis is costly and far from perfect. Five-year survival on the treatment is lower than that for colon cancer. Despite this, the evidence base for current practice patterns in dialysis is alarmingly thin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
